- Home
- Publications
- Publication Search
- Publication Details
Title
Novel drug targets for idiopathic pulmonary fibrosis
Authors
Keywords
-
Journal
Expert Review of Respiratory Medicine
Volume 10, Issue 4, Pages 393-405
Publisher
Informa UK Limited
Online
2016-02-09
DOI
10.1586/17476348.2016.1152186
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Intraindividual Response to Treatment with Pirfenidone in Idiopathic Pulmonary Fibrosis
- (2015) Benjamin Loeh et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- TOLLIP,MUC5B, and the Response toN-Acetylcysteine among Individuals with Idiopathic Pulmonary Fibrosis
- (2015) Justin M. Oldham et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline
- (2015) Ganesh Raghu et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Development of Novel Agents for Idiopathic Pulmonary Fibrosis
- (2015) Thomas G. O'Riordan et al. CHEST
- Pharmacological treatment of idiopathic pulmonary fibrosis: an update
- (2015) Paolo Spagnolo et al. DRUG DISCOVERY TODAY
- Missing data in IPF trials: do not let methodological issues undermine a major therapeutic breakthrough
- (2015) Gabriel Thabut et al. EUROPEAN RESPIRATORY JOURNAL
- Switching to nintedanib after discontinuation of pirfenidone due to adverse events in IPF
- (2015) Katrin Milger et al. EUROPEAN RESPIRATORY JOURNAL
- αvβ6 integrin may be a potential prognostic biomarker in interstitial lung disease
- (2015) Gauri Saini et al. EUROPEAN RESPIRATORY JOURNAL
- Idiopathic pulmonary fibrosis: Recent advances on pharmacological therapy
- (2015) P. Spagnolo et al. PHARMACOLOGY & THERAPEUTICS
- New guideline on treatment of idiopathic pulmonary fibrosis
- (2015) Paolo Spagnolo et al. Lancet Respiratory Medicine
- Association of hospital admission and forced vital capacity endpoints with survival in patients with idiopathic pulmonary fibrosis: analysis of a pooled cohort from three clinical trials
- (2015) Michael T Durheim et al. Lancet Respiratory Medicine
- Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study
- (2015) R Gisli Jenkins et al. Lancet Respiratory Medicine
- All-Cause Mortality Rate in Patients with Idiopathic Pulmonary Fibrosis. Implications for the Design and Execution of Clinical Trials
- (2014) Talmadge E. King et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The Role of Bacteria in the Pathogenesis and Progression of Idiopathic Pulmonary Fibrosis
- (2014) Phillip L. Molyneaux et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- IPF clinical trial design and endpoints
- (2014) Steven D. Nathan et al. CURRENT OPINION IN PULMONARY MEDICINE
- Safety and pharmacokinetics of nintedanib and pirfenidone in idiopathic pulmonary fibrosis
- (2014) Takashi Ogura et al. EUROPEAN RESPIRATORY JOURNAL
- Prestress in the extracellular matrix sensitizes latent TGF-β1 for activation
- (2014) Franco Klingberg et al. JOURNAL OF CELL BIOLOGY
- A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
- (2014) Talmadge E. King et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
- (2014) Luca Richeldi et al. NEW ENGLAND JOURNAL OF MEDICINE
- A New Hope for Idiopathic Pulmonary Fibrosis
- (2014) Gary M. Hunninghake NEW ENGLAND JOURNAL OF MEDICINE
- Randomized Trial of Acetylcysteine in Idiopathic Pulmonary Fibrosis
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Pirfenidone in Idiopathic Pulmonary Fibrosis: Real-Life Experience from a German Tertiary Referral Center for Interstitial Lung Diseases
- (2014) Ute Oltmanns et al. RESPIRATION
- Dyspnoea and comorbidity contribute to anxiety and depression in interstitial lung disease
- (2014) Anne E. Holland et al. RESPIROLOGY
- S11 Pirfenidone Post-authorisation Safety Registry (passport)-interim Analysis Of Ipf Treatment
- (2014) T. Maher et al. THORAX
- Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001–11
- (2014) Ganesh Raghu et al. Lancet Respiratory Medicine
- Combination therapy: the future of management for idiopathic pulmonary fibrosis?
- (2014) Wim A Wuyts et al. Lancet Respiratory Medicine
- Future Directions in Idiopathic Pulmonary Fibrosis Research. An NHLBI Workshop Report
- (2013) Timothy S. Blackwell et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Animal Models of Fibrotic Lung Disease
- (2013) Bethany B. Moore et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Treatment of Idiopathic Pulmonary Fibrosis With Ambrisentan
- (2013) Ganesh Raghu ANNALS OF INTERNAL MEDICINE
- Klinische Erfahrungen mit Pirfenidon in der Therapie der idiopathischen Lungenfibrose
- (2013) F. Bonella et al. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
- Macitentan for the treatment of idiopathic pulmonary fibrosis: the randomised controlled MUSIC trial
- (2013) Ganesh Raghu et al. EUROPEAN RESPIRATORY JOURNAL
- Association Between the MUC5B Promoter Polymorphism and Survival in Patients With Idiopathic Pulmonary Fibrosis
- (2013) Anna L. Peljto et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Human iPS cell–derived alveolar epithelium repopulates lung extracellular matrix
- (2013) Mahboobe Ghaedi et al. JOURNAL OF CLINICAL INVESTIGATION
- A Phase One, Open Label, Multi-Dose Study To Evaluate the Safety, Tolerability, and Biologic Effects of Three Doses of IW001 in Patients with Idiopathic Pulmonary Fibrosis (IPF)
- (2013) K. Rothhaar et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Pre-transplant antibodies to Kα1 tubulin and collagen-V in lung transplantation: Clinical correlations
- (2013) Venkataswarup Tiriveedhi et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Preclinical SPECT/CT Imaging of v 6 Integrins for Molecular Stratification of Idiopathic Pulmonary Fibrosis
- (2013) A. E. John et al. JOURNAL OF NUCLEAR MEDICINE
- The Triterpenoid CDDO-Me Inhibits Bleomycin-Induced Lung Inflammation and Fibrosis
- (2013) Ajit A. Kulkarni et al. PLoS One
- Type V Collagen Induced Tolerance Suppresses Collagen Deposition, TGF-β and Associated Transcripts in Pulmonary Fibrosis
- (2013) Ragini Vittal et al. PLoS One
- Recombinant human serum amyloid P in healthy volunteers and patients with pulmonary fibrosis
- (2013) M.R. Dillingh et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Safety and efficacy of pirfenidone in idiopathic pulmonary fibrosis in clinical practice
- (2013) Ryo Okuda et al. RESPIRATORY MEDICINE
- Therapy for Fibrotic Diseases: Nearing the Starting Line
- (2013) S. L. Friedman et al. Science Translational Medicine
- Connective tissue disease related fibrotic lung disease: high resolution computed tomographic and pulmonary function indices as prognostic determinants
- (2013) Simon L F Walsh et al. THORAX
- Depression in patients with idiopathic pulmonary fibrosis
- (2013) Akhtar A. Akhtar et al. Chronic Respiratory Disease
- Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials
- (2013) Joyce S Lee et al. Lancet Respiratory Medicine
- Rare lung disease and orphan drug development
- (2013) Paolo Spagnolo et al. Lancet Respiratory Medicine
- Idiopathic Pulmonary Fibrosis
- (2012) Roland M. du Bois et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Idiopathic Pulmonary Fibrosis: Clinically Meaningful Primary Endpoints in Phase 3 Clinical Trials
- (2012) Ganesh Raghu et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- A Placebo-Controlled Randomized Trial of Warfarin in Idiopathic Pulmonary Fibrosis
- (2012) Imre Noth et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Molecular Mechanisms in Progressive Idiopathic Pulmonary Fibrosis
- (2012) Mark P. Steele et al. Annual Review of Medicine
- Is Obstructive Sleep Apnea a Cause of Idiopathic Pulmonary Fibrosis?
- (2012) David J. Lederer et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Idiopathic Pulmonary Fibrosis: Phenotypes and Comorbidities
- (2012) Charlene D. Fell CLINICS IN CHEST MEDICINE
- Chronic hypersensitivity pneumonitis: high resolution computed tomography patterns and pulmonary function indices as prognostic determinants
- (2012) Simon L. F. Walsh et al. EUROPEAN RADIOLOGY
- Prevalence and prognosis of unclassifiable interstitial lung disease
- (2012) Christopher J. Ryerson et al. EUROPEAN RESPIRATORY JOURNAL
- The evolving pharmacotherapy of pulmonary fibrosis
- (2012) Harpreet K Lota et al. EXPERT OPINION ON PHARMACOTHERAPY
- Prednisone, Azathioprine, andN-Acetylcysteine for Pulmonary Fibrosis
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Interobserver Variability in the CT Assessment of Honeycombing in the Lungs
- (2012) Takeyuki Watadani et al. RADIOLOGY
- Treating idiopathic pulmonary fibrosis with the addition of co-trimoxazole: a randomised controlled trial
- (2012) Ludmila Shulgina et al. THORAX
- BUILD-3: A Randomized, Controlled Trial of Bosentan in Idiopathic Pulmonary Fibrosis
- (2011) Talmadge E. King et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Gastroesophageal Reflux Therapy Is Associated with Longer Survival in Patients with Idiopathic Pulmonary Fibrosis
- (2011) Joyce S. Lee et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Forced Vital Capacity in Patients with Idiopathic Pulmonary Fibrosis
- (2011) Roland M. du Bois et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
- (2011) Ganesh Raghu et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Honeycomb Lung: History and Current Concepts
- (2011) Hiroaki Arakawa et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Lung Transplant in Idiopathic Pulmonary Fibrosis
- (2011) Timothy J. George ARCHIVES OF SURGERY
- Bronchoalveolar lavage pepsin in acute exacerbation of idiopathic pulmonary fibrosis
- (2011) J. S. Lee et al. EUROPEAN RESPIRATORY JOURNAL
- Idiopathic pulmonary fibrosis
- (2011) Talmadge E King et al. LANCET
- Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
- (2011) Paul W Noble et al. LANCET
- Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis
- (2011) Luca Richeldi et al. NEW ENGLAND JOURNAL OF MEDICINE
- A novel single-chain-Fv antibody against connective tissue growth factor attenuates bleomycin-induced pulmonary fibrosis in mice
- (2011) XIHUA WANG et al. RESPIROLOGY
- Depression is a common and chronic comorbidity in patients with interstitial lung disease
- (2011) CHRISTOPHER J. RYERSON et al. RESPIROLOGY
- Clinical Course and Prediction of Survival in Idiopathic Pulmonary Fibrosis
- (2010) Brett Ley et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Pulmonary Hypertension and Idiopathic Pulmonary Fibrosis
- (2010) Laszlo Farkas et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- A novel, orally active LPA1 receptor antagonist inhibits lung fibrosis in the mouse bleomycin model
- (2010) JS Swaney et al. BRITISH JOURNAL OF PHARMACOLOGY
- Depression and Functional Status Are Strongly Associated With Dyspnea in Interstitial Lung Disease
- (2010) Christopher J. Ryerson et al. CHEST
- Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology
- (2010) C. Vancheri et al. EUROPEAN RESPIRATORY JOURNAL
- TGF-beta driven lung fibrosis is macrophage dependent and blocked by Serum amyloid P
- (2010) Lynne A. Murray et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Pharmacokinetic and Pharmacodynamic Characterization of an Oral Lysophosphatidic Acid Type 1 Receptor-Selective Antagonist
- (2010) J. S. Swaney et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Allosteric inhibition of lysyl oxidase–like-2 impedes the development of a pathologic microenvironment
- (2010) Vivian Barry-Hamilton et al. NATURE MEDICINE
- The pathogenesis of idiopathic pulmonary fibrosis
- (2010) William R. Coward et al. Therapeutic Advances in Respiratory Disease
- Circulating Fibrocytes Are an Indicator of Poor Prognosis in Idiopathic Pulmonary Fibrosis
- (2009) Antje Moeller et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Pirfenidone in idiopathic pulmonary fibrosis
- (2009) H. Taniguchi et al. EUROPEAN RESPIRATORY JOURNAL
- Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial
- (2009) Talmadge E King et al. LANCET
- Molecular Phenotypes Distinguish Patients with Relatively Stable from Progressive Idiopathic Pulmonary Fibrosis (IPF)
- (2009) Kathy Boon et al. PLoS One
- Pulmonary Rehabilitation in Interstitial Lung Disease
- (2008) Alicia Ferreira et al. CHEST
- Computed Tomography Findings in Pathological Usual Interstitial Pneumonia
- (2007) Hiromitsu Sumikawa et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Partial Inhibition of Integrin αvβ6 Prevents Pulmonary Fibrosis without Exacerbating Inflammation
- (2007) Gerald S. Horan et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- BUILD-1: A Randomized Placebo-controlled Trial of Bosentan in Idiopathic Pulmonary Fibrosis
- (2007) Talmadge E. King et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The bleomycin animal model: A useful tool to investigate treatment options for idiopathic pulmonary fibrosis?
- (2007) Antje Moeller et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search